May 9, 2020

If you look at studies from 40 years ago, there was always the mention of using insulin in type 2 patients. Then in the 90’s when glargine first came out, Sanofi worked hard to bring across the idea of resting the pancreas by starting their long acting insulin in type 2 patients.

As educators many of us have made the case of starting basal insulin sooner to save pancreatic beta cell function.

This week our intern, Taylor Simmons, brings us a presentation from Dr. Irl Hirsch providing even more compelling reasons to start insulin sooner.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief